Tess Egginton

The Japan Ministry of Health, Labour and Welfare has approved Genmab's TIVDAK (tisotumab vedotin) for the treatment of advanced or recurrent cervical cancer that...

Chiesi Group, a global biopharmaceutical company headquartered in Parma, Italy, has made a major investment in Nerviano (Milan, Italy), with the construction of a...

The return on investment in pharma research and development (R&D) has increased from the previous year, with GLP-1 drugs helping to boost growth, according...